Article
Author(s):
San Francisco - Individualization of drug therapy is becoming a reality with the recognition that the response to drugs varies as a result of sequence variants in genes encoding drug-metabolizing enzymes, drug transporters, or drug targets.
Polynucleotide Therapy Shows Promise in Scar and Burn Management
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Jeff Stark, MD: Insights on the Approval of Bimekizumab for HS
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Maximizing the 2-Fold Benefits of Your Charitable Donations
Conference Recap: 2024 Society of Dermatology Physician Associates Fall Dermatology Conference